White label ELPA - ClinicalTrials.eu

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Recruiting

3 1 1
Investigated diseases:
- Chronic rhinosinusitis with nasal polyps
Investigated drugs:
- Lebrikizumab
- Mometasone Furoate
+5
Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

Recruiting

3 1 1 1
Investigated diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated drugs:
- Prednisone
- Vedolizumab
Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

Recruiting

2 1 1 1
Investigated diseases:
- Colorectal cancer metastatic
Investigated drugs:
Study on Stopping Prednisolone Early in Patients with Negative FDG-PET/CT and Idiopathic Retroperitoneal Fibrosis

Recruiting

3 1 1 1
Investigated diseases:
- Retroperitoneal fibrosis
Investigated drugs:
- Prednisolone
Study on the Effects of Ketoprofen and Drug Combination in Patients Undergoing Pleurodesis Surgery for Pneumothorax

Recruiting

3 1 1
Investigated diseases:
- Pneumothorax
Investigated drugs:
Study on Nefopam for Reducing Postoperative Pain in Adults After Total Knee Replacement Surgery

Recruiting

3 1 1
Investigated drugs:
Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+6
Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

Recruiting

3 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Mirikizumab
+3
Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery

Recruiting

3 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
- Rivaroxaban
Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

Recruiting

3 1 1 1
Investigated diseases:
- Neonatal respiratory distress syndrome
Investigated drugs:
- Phospholipid Fraction, Bovine Lung
- Poractant Alfa

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies